U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548697) titled 'A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma' on April 16.
Brief Summary: This study is a single arm, open label, dose exploring clinical study to evaluate the safety, efficacy, metabolic kinetics and pharmacodynamics of CT1182 cells in patients with relapsed / refractory B-cell non Hodgkin lymphoma (r/r B-NHL).
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
B-cell Non Hodgkin Lymphoma (NHL)
DLBCL - Diffuse Large B Cell Lymphoma
Follicular Lymphoma (FL)
Intervention:
BIOLOGICAL: CT1182 injection
CT1182 ...